In terms of treatment, USPs can be used as cancer therapeutic targets, such as inhibitors of USP1, USP4, USP7, USP9X, and USP33 for prostate cancer, lung cancer, breast cancer, and hematological malignancies, among others [26–30]. Here, USP9X is linked to breast carcinoma.